{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:57:43Z","timestamp":1760029063205,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ahj.2008.01.029","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T09:40:04Z","timestamp":1210153204000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis"],"prefix":"10.1016","volume":"156","author":[{"given":"Dennis T.","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack V.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.01.029_bib1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.01.029_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000013952.86046.DD","article-title":"Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association","volume":"105","author":"Grundy","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.01.029_bib3","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1161\/01.CIR.0000013957.30622.05","article-title":"Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients","volume":"105","author":"Smith","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.01.029_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.293.12.1501","article-title":"Diabetes and coronary revascularization","volume":"293","author":"Flaherty","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.01.029_bib5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.0000129767.45513.71","article-title":"Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon- expandable stent in the treatment of patients with de novo coronary artery lesions) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.01.029_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jacc.2004.10.075","article-title":"Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial","volume":"45","author":"Hermiller","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.01.029_bib7","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.105.562421","article-title":"Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial","volume":"112","author":"Sabate","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.01.029_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehl412","article-title":"The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus","volume":"28","author":"Daemen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.01.029_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/hrt.2005.070698","article-title":"Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials","volume":"92","author":"Stettler","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2008.01.029_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jacc.2006.09.045","article-title":"Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization","volume":"49","author":"Berry","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.01.029_bib11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug- eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib12","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.01.029_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"Tu","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2008.01.029_bib16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study","volume":"369","author":"Lipscombe","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.01.029_bib17","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/sim.2328","article-title":"A comparison of propensity score methods: a case- study estimating the effectiveness of post-AMI statin use","volume":"25","author":"Austin","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib18","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"year":"1997","author":"Klein","series-title":"Survival analysis: techniques for censored and truncated data","key":"10.1016\/j.ahj.2008.01.029_bib20"},{"key":"10.1016\/j.ahj.2008.01.029_bib21","article-title":"A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus- eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(04)16850-5","article-title":"A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [see comment]","volume":"364","author":"Babapulle","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.01.029_bib24","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta- analysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.01.029_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jacc.2006.02.060","article-title":"Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial","volume":"48","author":"Pinto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.01.029_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.amjmed.2003.10.039","article-title":"Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies","volume":"116","author":"Alter","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2008.01.029_bib27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.291.15.1864","article-title":"Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox","volume":"291","author":"Ko","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.01.029_bib28","first-page":"417","article-title":"Controlling bias in observational studies: a review","volume":"35","author":"Cochran","year":"1973","journal-title":"Sankhya Series A."},{"key":"10.1016\/j.ahj.2008.01.029_bib29","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:36:01Z","timestamp":1757568961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0002870308001336"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.01.029","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}